Your health deserves data, not risk
Food and Drug Administrations drug shortage list since 2022
This assessment allows your provider to establish safe starting doses, appropriate monitoring frequency, and realistic expectations for your individual response pattern
If your score identifies significant gaps or if you want to work through what to fix, in what order, with someone holding you accountable you can book a 20-minute call with Andre directly
GLP-1 RA Multidistrict Litigation Overview While there are no current class action lawsuits against the manufacturers of semaglutide products, there is an ongoing MDL, or multi-district litigation, regarding these drugs
doi: 10.1186/s12866-019-1685-2 240 RizzettoLFavaFTuohyKMSelmiC